Publication Year 1996

Dick, T. P., T. Ruppert, M. Groettrup, P. M. Kloetzel, L. Kuehn, U. H. Koszinowski, S. Stevanovic, H. Schild, and H.-G. Rammensee. 1996. Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell

Diehl, M., C. Münz, W. Keilholz, S. Stevanovic, N. Holmes, Y. W. Loke, and H.-G. Rammensee. 1996. Nonclassical HLA-G molecules are classical peptide presenters. Curr. Biol.

Friede, T., V. Gnau, G. Jung, W. Keilholz, S. Stevanovic, and H.-G. Rammensee. 1996. Natural ligand motifs closely related HLA-DR4 molecules predict features of rheumatoid arthritis associated peptides. Biochem. Biophys. Acta

Groettrup, M., A. Soza, M. Eggers, L. Kuehn, T. P. Dick, H. Schild, H.-G. Rammensee, U. H. Koszinowski, and P.-M. Kloetzel. 1996. A role for the proteasome regulator PA28a in antigen presentation. Nature

Kikuchi, A., T. Sakaguchi, K. Miwa, Y. Takamiya, H. G. Rammensee, Y. Kaneko, and M. Takiguchi. 1996. Binding of nonamer peptides to three HLA-B51 molecules which differ by a single amino acid substitution in the A-pocket. Immunogenetics.

Lammert, E., D. Arnold, H. G. Rammensee, and H. Schild. 1996. Expression levels of stress protein gp96 are not limiting for major histocompatibility complex class I-restricted antigen presentation. Eur. J. Immunol.

Mayer, S., C. SCHEIBENBOGEN,Author), K. H. LEE, W. Keilholz, S. Stevanovic, H. G. Rammensee, and U. KEILHOLZ. 1996. A SENSITIVE PROLIFERATION ASSAY TO DETERMINE THE SPECIFIC T CELL RESPONSE AGAINST HLA A2.1 BINDING PEPTIDES. JOURNAL. OF. IMMUNOLOGICAL. METHODS

Merkel, F., R. Kalluri, M. Marx, U. Enders, S. Stevanovic, G. Giegerich, E. G. Neilson, H. G. Rammensee, B. G. Hudson, and M. Weber. 1996. Autoreactive T-cells in Goodpasture's syndrome recognize the N-terminal NC1 domain on alpha 3 type IV collagen. Kidney Int.

Rammensee, H.-G. 1996. Physiological function of MHC molecules. In Peptides in Immunology. C.H. Schneider, editor. John Wiley and Sons, Ltd. 39-53.

Rammensee, H. G. 1996. Antigen presentation--recent developments. Int. Arch. Allergy Immunol.

Rammensee, H. G. and K. F. LINDHAL. 1996. LESS SCHOLASTICISM, MORE EXACT IMMUNOLOGY: EDITORIAL OVERVIEW. CURRENT. OPINION. IN IMMUNOLOGY

Reizis, B., F. Mor, M. Eisenstein, H. Schild, S. Stevanovic, H.-G. Rammensee, and I. Cohen. 1996. The peptide binding specificity of the MHC class II I-A molecule of the Lewis rat, RT1.B. Int. Immunol.

Schild, H. and H.-G. Rammensee. 1996. Peptide based vaccines. In Concepts in vaccine development. S.H.E. Kaufmann, editor. Walter de Gruyter, Berlin,New York. 303-325.

Shiga, H., T. Shioda, H. Tomiyama, Y. Takamiya, S. OKA, S. Kimura, Y. Yamaguchi, T. GOJOUBORI, H. G. Rammensee, K. Miwa, and M. TAKIGUCHI,Author). 1996. IDENTIFICATION OF MULTIPLE HIV 1 CYTOTOXIC T CELL EPITOPES PRESENTED BY HUMAN LEUKOCYTE ANTIGEN B35 MOLECULES. Aids

Steinle, A., K. Falk, O. Rötzschke, V. Gnau, S. Stevanovic, G. Jung, D. J. Schendel, and H. G. Rammensee. 1996. Motif of HLA-B*3503 peptide ligands. Immunogenetics

Stevanovic, S. and H.-G. Rammensee. 1996. The structure of T cell epitopes. In Structure of antigens. M.H.V. Van Regenmortel, editor. CRC Press, New York. 61-90.

TURECI, O., U. Sahin, I. SCHOBERT, M. KOSLOWSKI, H. Schmitt, H. J. Schild, F. STENNER, G. SEITZ, H. G. Rammensee, and M. PFREUNDSCHUH,Author). 1996. THE SSX 2 GENE, WHICH IS INVOLVED IN THE T(X 18) TRANSLOCATION OF SYNOVIAL SARCOMAS, CODES FOR THE HUMAN TUMOR ANTIGEN HOM MEL 40. CANCER RESEARCH.

Vartdal, F., B. H. Johansen, T. Friede, C. J. Thorpe, S. Stevanovic, J. E. ERIKSEN, K. Sletten, E. Thorsby, H. G. Rammensee, and L. M. Sollid. 1996. THE PEPTIDE BINDING MOTIF OF THE DISEASE ASSOCIATED HLA DQ (ALPHA 1 ASTERISK 0501, BETA 1 ASTERISK 0201) MOLECULE. EUROPEAN. JOURNAL. OF. IMMUNOLOGY